Vinit K Srivastava1, Pravin K Das2, Sujeet Ks Gautam3, Parineeta Jaisawal4, Venkat N Kadiyala5, Sonal Rambhad5. 1. Senior Consultant, Department of Anaesthesiology, Apollo Hospitals , Bilaspur, Chhattisgarh, India . 2. Associate Professor, Department of Anaesthesiology, Dr RML Institute of Medical Sciences , Lucknow, Uttar Pradesh, India . 3. Assistant Professor, Department of Anaesthesiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences , Lucknow, Uttar Pradesh, India . 4. Consultant, Department of Anaesthesiology, Apollo Hospitals , Bilaspur, Chhattisgarh, India . 5. DNB Student, Department of Anaesthesiology, Apollo Hospitals , Bilaspur, Chhattisgarh, India .
Abstract
INTRODUCTION: Topical application of volatile anaesthetic agents has been found to attenuate the response to a mechanical stimulus; however, this effect of volatile anaesthetic on perception of pain during venous cannulation is not known. AIM: To compare the efficacy of topically administered volatile anaesthetic agents for attenuating venous cannulation pain. MATERIALS AND METHODS: This prospective, randomized, placebo controlled and double blind study was conducted on 120 patients, aged 20-60years. They were of American Society of Anaesthesiologists (ASA) I or II physical status, of either sex, planned for elective surgeries. These patients were randomized into 4 groups, of 30 each. Equipotent doses of halothane (1ml), isoflurane (1.5ml), sevoflurane (2.7ml) and sterile water (2.5ml; Control) were topically administered on the volar surface of forearm wrapped with cotton and aluminium foil; venous cannulation was performed with 18G intravenous cannula after 30 min. These patients were assessed for the incidence and severity of pain upon venous cannulation {visual analog scale (VAS), 0-100mm; 0 = no pain and 100 = worst imaginable pain}. Data were analysed by one-way ANOVA, Chi-square test and Kruskal-Wallis test. The p<0.05 was considered as significant. RESULTS: A significant reduction in the incidence of venous cannulation pain was observed in the halothane (79%) group as compared to control (100%; p<0.05), isoflurane (100%; p<0.05) and sevoflurane (100%; p<0.05) groups. The severity of venous cannulation pain as assessed by median (interquartile range, Q1-Q3). VAS scores was reduced in the halothane {10 (10-20); p<0.001}, isoflurane {20 (10-30); p<0.001} and sevoflurane {20 (20-30); p<0.001} groups as compared to the control group {40 (30-40)}; VAS score in the halothane group was significantly less as compared to isoflurane (p<0.05) and sevoflurane (p<0.05) groups. CONCLUSION: Topical application of halothane is most effective in reducing incidence and severity of venous cannulation pain; however, topical application of isoflurane and sevoflurane decreases only the severity of venous cannulation pain.
RCT Entities:
INTRODUCTION: Topical application of volatile anaesthetic agents has been found to attenuate the response to a mechanical stimulus; however, this effect of volatile anaesthetic on perception of pain during venous cannulation is not known. AIM: To compare the efficacy of topically administered volatile anaesthetic agents for attenuating venous cannulation pain. MATERIALS AND METHODS: This prospective, randomized, placebo controlled and double blind study was conducted on 120 patients, aged 20-60years. They were of American Society of Anaesthesiologists (ASA) I or II physical status, of either sex, planned for elective surgeries. These patients were randomized into 4 groups, of 30 each. Equipotent doses of halothane (1ml), isoflurane (1.5ml), sevoflurane (2.7ml) and sterile water (2.5ml; Control) were topically administered on the volar surface of forearm wrapped with cotton and aluminium foil; venous cannulation was performed with 18G intravenous cannula after 30 min. These patients were assessed for the incidence and severity of pain upon venous cannulation {visual analog scale (VAS), 0-100mm; 0 = no pain and 100 = worst imaginable pain}. Data were analysed by one-way ANOVA, Chi-square test and Kruskal-Wallis test. The p<0.05 was considered as significant. RESULTS: A significant reduction in the incidence of venous cannulation pain was observed in the halothane (79%) group as compared to control (100%; p<0.05), isoflurane (100%; p<0.05) and sevoflurane (100%; p<0.05) groups. The severity of venous cannulation pain as assessed by median (interquartile range, Q1-Q3). VAS scores was reduced in the halothane {10 (10-20); p<0.001}, isoflurane {20 (10-30); p<0.001} and sevoflurane {20 (20-30); p<0.001} groups as compared to the control group {40 (30-40)}; VAS score in the halothane group was significantly less as compared to isoflurane (p<0.05) and sevoflurane (p<0.05) groups. CONCLUSION: Topical application of halothane is most effective in reducing incidence and severity of venous cannulation pain; however, topical application of isoflurane and sevoflurane decreases only the severity of venous cannulation pain.
Authors: James M Sonner; Joseph F Antognini; Robert C Dutton; Pamela Flood; Andrew T Gray; R Adron Harris; Gregg E Homanics; Joan Kendig; Beverley Orser; Douglas E Raines; Ira J Rampil; James Trudell; Bryce Vissel; Edmond I Eger Journal: Anesth Analg Date: 2003-09 Impact factor: 5.108
Authors: A Fassoulaki; S H Lockhart; B A Freire; N Yasuda; E I Eger; R B Weiskopf; B H Johnson Journal: Anesthesiology Date: 1991-03 Impact factor: 7.892
Authors: S Petersen-Felix; L Arendt-Nielsen; P Bak; D Roth; M Fischer; P Bjerring; A M Zbinden Journal: Br J Anaesth Date: 1995-07 Impact factor: 9.166
Authors: Mayank Aranke; Cynthia T Pham; Melis Yilmaz; Jason K Wang; Vwaire Orhurhu; Daniel An; Elyse M Cornett; Alan David Kaye; Anh L Ngo; Farnad Imani; Reza Farahmand Rad; Giustino Varrassi; Omar Viswanath; Ivan Urits Journal: Anesth Pain Med Date: 2021-02-24